Trial Profile
A prospective Randomised Controlled Trial assessing recombinant LH supplementation in patients with a relative reduction in Luteinising Hormone (LH) levels during In Vitro Fertilisation/Intracytoplasmic sperm Injection (IVF/ICSI) treatment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Lutropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms IVFA Luveris
- 08 Jun 2016 Status changed from recruiting to completed.
- 13 Jul 2011 New trial record